The Clinical and Development Team at Infant Bacterial Therapeutics is responsible for overseeing the design, implementation, and management of clinical trials aimed at developing drugs that influence the infant microbiome. This team ensures all clinical studies meet regulatory standards and contribute valuable data towards preventing or treating rare diseases in infants.
View all